Rating Change
Citizens reiterated its Market Outperform rating on Biomea Fusion, Inc. (NASDAQ:BMEA) on October 14, 2026.
reiterateNASDAQ:BMEA
Citizens Reiterates Market Outperform Rating on Biomea Fusion, Inc. (BMEA)
Citizens reiterated its Market Outperform rating on Biomea Fusion, Inc. (NASDAQ:BMEA) on October 14, 2026.
At publication ·
What changed
Biomea Fusion, Inc. (NASDAQ:BMEA) · reiterate
- Firm
- Citizens
- Rating
- Market Outperform to Market Outperform
- Price at event
- $0.84
- Market capitalization
- $90.4M
At a glance
Key takeaways
- Citizens reiterated a Market Outperform rating on Biomea Fusion (BMEA) on October 14, 2026, with the stock trading at $0.84 and a market cap of $90.4 million.
Market Context
Biomea Fusion, Inc. operates in the Healthcare sector. The stock currently trades at $0.84 with a market capitalization of $90.4M.
Analyst coverage from Citizens provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Biomea Fusion, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Biomea Fusion, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 14, 2026 | Citizens | Market Outperform | N/A |
| Oct 14, 2026 | HC Wainwright & Co. | Buy | N/A |
| Oct 07, 2026 | Brookline Capital | Buy | N/A |
| May 05, 2026 | Citizens | Market Outperform | N/A |
| Apr 28, 2026 | D. Boral Capital | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View BMEA Stock Page
Frequently Asked Questions
What does the Market Outperform rating mean for BMEA?
A rating of Market Outperform from Citizens reflects the analyst's outlook on Biomea Fusion, Inc. (NASDAQ:BMEA). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the BMEA forecast page.
